Pfizer Indefinite- lived intangible impairment increased by 0.2% to $126.42B in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Growth indicates investment in intellectual property, brand equity, or customer relationships.
The total gross carrying value of identifiable intangible assets, such as brands, customer lists, or software, excluding...
Common in service-oriented and technology-heavy firms.
other_intangible_assets_gross_excluding_goodwill| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $126.23B | $126.42B |
| QoQ Change | — | +0.2% |